160 related articles for article (PubMed ID: 21987934)
21. [Vaccination against human papillomavirus. Implementation and efficacy against cervical cancer control].
Bégué P; Henrion R; Blanc B; Girard M; Sancho-Garnier H
Bull Acad Natl Med; 2007 Dec; 191(9):1805-16; discussion 1816-7. PubMed ID: 18663976
[TBL] [Abstract][Full Text] [Related]
22. Upgrading public health programs for human papillomavirus prevention and control is possible in low- and middle-income countries.
Steben M; Jeronimo J; Wittet S; Lamontagne DS; Ogilvie G; Jensen C; Smith J; Franceschi S
Vaccine; 2012 Nov; 30 Suppl 5():F183-91. PubMed ID: 23199962
[TBL] [Abstract][Full Text] [Related]
23. Recommendations for cervical cancer prevention in Latin America and the Caribbean.
Muñoz N; Franco EL; Herrero R; Andrus JK; de Quadros C; Goldie SJ; Bosch FX
Vaccine; 2008 Aug; 26 Suppl 11():L96-L107. PubMed ID: 18945407
[TBL] [Abstract][Full Text] [Related]
24. Programmatic issues in the implementation of an HPV vaccination program to prevent cervical cancer.
Ault K; Reisinger K
Int J Infect Dis; 2007 Nov; 11 Suppl 2():S26-8. PubMed ID: 18162242
[TBL] [Abstract][Full Text] [Related]
25. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
[TBL] [Abstract][Full Text] [Related]
26. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.
Sankaranarayanan R; Bhatla N; Gravitt PE; Basu P; Esmy PO; Ashrafunnessa KS; Ariyaratne Y; Shah A; Nene BM
Vaccine; 2008 Aug; 26 Suppl 12():M43-52. PubMed ID: 18945413
[TBL] [Abstract][Full Text] [Related]
27. Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing.
Schiffman M
Cancer; 2007 Jun; 111(3):145-53. PubMed ID: 17487850
[TBL] [Abstract][Full Text] [Related]
28. HPV vaccines: state of the art.
D'Andrilli G; Bovicelli A; Giordano A
J Cell Physiol; 2010 Sep; 224(3):601-4. PubMed ID: 20432468
[TBL] [Abstract][Full Text] [Related]
29. Commentary: Health inequity could increase in poor countries if universal HPV vaccination is not adopted.
Franco EL
BMJ; 2007 Aug; 335(7616):378-9. PubMed ID: 17717367
[No Abstract] [Full Text] [Related]
30. Understanding and overcoming barriers to human papillomavirus vaccine acceptance.
Zimet GD
Curr Opin Obstet Gynecol; 2006 Feb; 18 Suppl 1():s23-8. PubMed ID: 16520681
[TBL] [Abstract][Full Text] [Related]
31. Cervical cancer: the second-generation vaccines move forward.
Tuma RS
J Natl Cancer Inst; 2009 Jun; 101(11):774-5. PubMed ID: 19470948
[No Abstract] [Full Text] [Related]
32. Strengthening prevention programs to eliminate cervical cancer in the Nordic countries.
Dillner L; Pagliusi S; Bray F; Lorincz A; Kjaer SK; Anttila A; Iversen OE; Dillner J; Lehtinen M; Paavonen J
Acta Obstet Gynecol Scand; 2008; 87(5):489-98. PubMed ID: 18446530
[TBL] [Abstract][Full Text] [Related]
33. Harnessing the power of prevention: human papillomavirus vaccines.
Mayeaux EJ
Curr Opin Obstet Gynecol; 2006 Feb; 18 Suppl 1():s15-21. PubMed ID: 16520680
[TBL] [Abstract][Full Text] [Related]
34. Overcoming the barriers to HPV vaccination in high-risk populations in the US.
Downs LS; Scarinci I; Einstein MH; Collins Y; Flowers L
Gynecol Oncol; 2010 Jun; 117(3):486-90. PubMed ID: 20303156
[TBL] [Abstract][Full Text] [Related]
35. The GARDASIL vaccine can prevent cervical carcinoma caused by human papilloma virus (HPV) (results from our participation and from the study carried out in Greece).
Ansstasiou-Fotaki P; Deligeoroglou E; Kreatsas G
Akush Ginekol (Sofiia); 2007; 46(3):17-20. PubMed ID: 18018777
[TBL] [Abstract][Full Text] [Related]
36. Cervical cancer vaccination indications, efficacy, and side effects.
Bayas JM; Costas L; Muñoz A
Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S11-4. PubMed ID: 18586311
[TBL] [Abstract][Full Text] [Related]
37. Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses.
Barnabas RV; Laukkanen P; Koskela P; Kontula O; Lehtinen M; Garnett GP
PLoS Med; 2006 May; 3(5):e138. PubMed ID: 16573364
[TBL] [Abstract][Full Text] [Related]
38. Prevention strategies against the human papillomavirus: the effectiveness of vaccination.
Stanley M
Gynecol Oncol; 2007 Nov; 107(2 Suppl 1):S19-23. PubMed ID: 17938013
[TBL] [Abstract][Full Text] [Related]
39. Impact of the human papilloma vaccine on cervical cancer.
Chan JK; Berek JS
J Clin Oncol; 2007 Jul; 25(20):2975-82. PubMed ID: 17617529
[TBL] [Abstract][Full Text] [Related]
40. Human papilloma virus vaccination: should it be mandatory?
Prasai S
JNMA J Nepal Med Assoc; 2008; 47(171):167-71. PubMed ID: 19079386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
